BASHER FRENZYSad to visit this board for a variety of reasons. First of all the sp is depressing to watch after a $1.57 march - only the bashers/shorters are happy with that because they have won the shorter battle. Secondly, reading the scathing nonesense here by the gleeful warts scattering this board is nauseating even for the heartiest stomachs. The only bright light I see right now sp wise is that we have to be near the bottom - I mean how can we go lower than this on a company with $6.5 million in the bank and $2.5 million rolling in each quarter. Tripp dropped the ball with the rollout and initial shock of CARE, however to his credit he has gone out of the way via CCs, Investor tel interviews, Linkedin, FAQs to counter this and educate us. That education shows a company that needs a CARE in order to operate in this telehealh environment. The AVRT program is not the leading solution for cancer treatment in the US, however we don't need 100% of that business when in fact about 1% would propel our market cap. This is a cancer diagnosis/treatment starved environment and we do have a modest solution. Tripp has stated there will be other affiliations announced in the near term so obviously he is working on them as we speak. Ichor and Mercer are still our friends and giants like Rexall are in the wings - there is also a hint of another Fortune 500 company out there. Tripp wants covid to convert to cancer treatment and no one can argue that is vision is not bang on - he is going after the big clients.
Sure, we would all like to see an immediate announcement of affiliation with Johnson and Johnson or Pfiser but thats not going to happen - we have to crawl before we walk. The optimists here believe that one morning we will see an NR announcing a big development with a big player and the sp will react accordingly. I am here simply because I believe that will happen and don't want to be on the outside looking in when it does - that will be a sad say for the shorters' accounts and I look forward to it.